Plasminogen activator system in smokers and non-smokers with and without periodontal disease.
暂无分享,去创建一个
[1] T. Köse,et al. Periodontal infections and pre-term low birth weight: a case-control study. , 2005, Journal of clinical periodontology.
[2] N. Buduneli,et al. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients. , 2004, Journal of clinical periodontology.
[3] G. K. Johnson,et al. Cigarette smoking and the periodontal patient. , 2004, Journal of periodontology.
[4] J. Lindholt,et al. Relationships between activators and inhibitors of plasminogen, and the progression of small abdominal aortic aneurysms. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[5] J. Echeverría,et al. Effects of smoking on periodontal tissues. , 2002, Journal of clinical periodontology.
[6] D. Webb,et al. Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man. , 2001, Cardiovascular research.
[7] F. Eggert,et al. Effects of smoking and treatment status on periodontal bacteria: evidence that smoking influences control of periodontal bacteria at the mucosal surface of the gingival crevice. , 2001, Journal of periodontology.
[8] P. Bartold,et al. Detection of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2(PAI-2) in gingival crevicular fluid from healthy, gingivitis and periodontitis patients. , 2000, Journal of clinical periodontology.
[9] L. Matsson,et al. Localization of plasminogen activators and plasminogen-activator inhibitors in human gingival tissues demonstrated by immunohistochemistry and in situ hybridization. , 1999, Archives of oral biology.
[10] J. Bergström,et al. Smoking and crevicular fluid levels of IL-6 and TNF-alpha in periodontal disease. , 1999, Journal of clinical periodontology.
[11] B. Nielsen,et al. Cancer invasion and tissue remodeling‐cooperation of protease systems and cell types , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[12] J. Bergström,et al. Influence of smoking on the outcome of periodontal surgery. A 5-year follow-up. , 1998, Journal of clinical periodontology.
[13] G. Dahlén,et al. The clinical and microbiological effects of non-surgical periodontal therapy in smokers and non-smokers. , 1998, Journal of clinical periodontology.
[14] R. Hirsch,et al. The effects of local anesthetic containing adrenaline on gingival blood flow in smokers and non-smokers. , 1997, Journal of clinical periodontology.
[15] N. Booth,et al. THE EFFECTS OF CHRONIC SMOKING ON THE FIBRINOLYTIC POTENTIAL OF PLASMA AND PLATELETS , 1997, British journal of haematology.
[16] N. Sun,et al. Chronic Nicotine Treatment Enhances Focal Ischemic Brain Injury and Depletes Free Pool of Brain Microvascular Tissue Plasminogen Activator in Rats , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] L. Matsson,et al. Aggravation of gingival inflammatory symptoms during pregnancy associated with the concentration of plasminogen activator inhibitor type 2 (PAI-2) in gingival fluid. , 1996, Journal of periodontal research.
[18] K. Winther,et al. Smoking further increases platelet activity in patients with mild hypertension , 1996, European journal of clinical investigation.
[19] M. Baker,et al. Biological and clinical aspects of plasminogen activator inhibitor type 2. , 1995, Blood.
[20] J. Brown,et al. Molecular characterization of plasminogen activators in human gingival crevicular fluid. , 1995, Archives of oral biology.
[21] R. Grimble,et al. Cigarette smoking influences cytokine production and antioxidant defences. , 1995, Clinical science.
[22] J. Wennström,et al. Acute-phase proteins and immunoglobulin G against Porphyromonas gingivalis in peri-implant crevicular fluid: a comparison with gingival crevicular fluid. , 1995, Clinical oral implants research.
[23] L. Matsson,et al. The plasminogen-activating system in gingival fluid from adults. An intra-individual study before and after treatment of gingivitis. , 1994, Scandinavian journal of dental research.
[24] G. Koch,et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. , 1994, Journal of periodontology.
[25] G. K. Johnson,et al. The effect of smoking on the response to periodontal therapy. , 1994, Journal of clinical periodontology.
[26] L. Granath,et al. Tissue plasminogen activator (t-PA) and placental plasminogen activator inhibitor (PAI-2) in gingival fluid from 8-9-year-old children. , 1993, Scandinavian journal of dental research.
[27] J. Bergström,et al. Occurrence of periopathogens in smoker and non-smoker patients. , 1992, Journal of clinical periodontology.
[28] R. Page,et al. Host Response Tests for Diagnosing Periodontal Diseases. , 1992, Journal of periodontology.
[29] B. Åstedt,et al. Tissue plasminogen activator and placental plasminogen activator inhibitor in human gingival fluid , 1991 .
[30] W. Haire,et al. Abnormal fibrinolysis in healthy male cigarette smokers: Role of plasminogen activator inhibitors , 1989, American journal of hematology.
[31] M. Curtis,et al. The total protein concentration of gingival crevicular fluid. Variation with sampling time and gingival inflammation. , 1988, Journal of clinical periodontology.
[32] I. Hägerstrand,et al. Cellular Localisation in Placenta of Placental Type Plasminogen Activator Inhibitor , 1986, Thrombosis and Haemostasis.
[33] A. Kjaeldgaard,et al. Long‐Term Treatment with Combined Oral Contraceptives and Cigarette Smoking Associated with Impaired Activity of Tissue Plasminogen Activator , 1986, Acta obstetricia et gynecologica Scandinavica.
[34] O. Saksela,et al. Plasminogen activation and regulation of pericellular proteolysis. , 1985, Biochimica et biophysica acta.
[35] C. Kluft,et al. Acute effect of smoking on fibrinolysis: increase in the activity level of circulating extrinsic (tissue‐type) plasminogen activator* , 1984, European journal of clinical investigation.
[36] L. Ossowski,et al. Antibodies to plasminogen activator inhibit human tumor metastasis , 1983, Cell.
[37] D. Deutsch,et al. Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.
[38] H. Löe,et al. PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION. , 1964, Acta odontologica Scandinavica.
[39] T. F. Walsh,et al. Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non-smokers. , 2003, Journal of clinical periodontology.
[40] L. Matsson,et al. Plasminogen activating capacity in gingival fluid from deteriorating and stable periodontal pockets. , 2002, Journal of periodontal research.
[41] I. Chestnutt,et al. Smoking and periodontal disease. , 2000, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[42] G. Koch,et al. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. , 1995, Journal of periodontology.
[43] R. Kent,et al. Evidence for cigarette smoking as a major risk factor for periodontitis. , 1993, Journal of periodontology.
[44] E. Kruithof,et al. Plasminogen activator inhibitors--a review. , 1988, Enzyme.
[45] K. Danø,et al. Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.